`
`
`
`
`
`
`
`
`mc/DUNN
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`Trademark Trial and Appeal Board
`P.O. Box 1451
`Alexandria, VA 22313-1451
`General Contact Number: 571-272-8500
`
`
`
`
`
`
`
`
`
`Mailed: October 25, 2017
`
`Opposition No. 91235993
`
`Jazz Pharmmaceuticals, Inc.
`
`
`v.
`
`
`
`By the Trademark Trial and Appeal Board:
`
`
`Novartis AG
`
`On September 11, 2017, Applicant filed a proposed amendment to its application
`
`Serial No. 87222187, with Opposer's consent, and Opposer's withdrawal of the
`
`opposition, contingent upon entry of the amendment.
`
`By the proposed amendment, Applicant seeks to amend the identification of
`
`goods by adding the wording, “all of the foregoing excluding pharmaceutical
`
`preparations and substances for the treatment or management of sleep
`
`disorders,” as underlined and bolded at the end of the recitation of goods:
`
`Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics;
`antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological
`pharmaceutical products; inhaled pharmaceutical preparations for the prevention and
`treatment of respiratory diseases and disorders; pharmaceutical preparations acting
`on the central nervous system; pharmaceutical preparations and substances for the
`prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations
`for the prevention and treatment of diseases and disorders of the autoimmune system,
`the metabolic system, the endocrine system, the musculo-skeletal system and the
`genitourinary system; pharmaceutical preparations for use in hematology and in
`tissue and organ transplantation; pharmaceutical preparations for the prevention and
`treatment of eye diseases and conditions; pharmaceutical preparations for the
`prevention and treatment of heart rhythm disorders; pharmaceutical preparations for
`
`
`
`
`
`Opposition No. 91235993
`
`
`the prevention and treatment of immune system related diseases and disorders;
`pharmaceutical preparations for the prevention and treatment of kidney diseases;
`pharmaceutical preparations
`for the prevention and treatment of diabetes;
`pharmaceutical preparations for the prevention and treatment of hypertension;
`pharmaceutical preparations for the prevention and treatment of skin disorders;
`pharmaceutical preparations for use in dermatology; pharmaceutical preparations for
`use in urology; pharmaceutical products for ophthalmological use; pharmaceutical
`products for the prevention and treatment of cancer and tumors; pharmaceutical
`preparations for the prevention and treatment of allergies; pharmaceutical products
`for the prevention and treatment of bone diseases; pharmaceutical products for the
`prevention and treatment of respiratory diseases and asthma, all of the forgoing
`excluding pharmaceutical and preparations and substances for the
`treatment or management of sleep disorders.
`
`The amendment is limiting in nature, as required by Trademark Rule 2.71(a).
`
`Because Opposer consents thereto, the amendment is approved and entered. See
`
`Trademark Rule 2.133(a).
`
`The contingency in Opposer's withdrawal having now been met, the opposition is
`
`dismissed in accordance with the agreement between the parties.
`
`
`
`2
`
`